STOCK TITAN

Multiplan Corporation Stock Price, News & Analysis

MPLN NYSE

Welcome to our dedicated page for Multiplan Corporation news (Ticker: MPLN), a resource for investors and traders seeking the latest updates and insights on Multiplan Corporation stock.

The MPLN news archive on Stock Titan captures the transition of MultiPlan Corporation into Claritev Corporation and documents the company’s ongoing role as a healthcare technology, data and insights provider. Press releases describe Claritev, formerly known as MultiPlan, as focused on making healthcare more affordable, transparent and fair for all participants in the U.S. healthcare system.

News items linked to MPLN cover several key themes. Earnings releases and financial updates detail quarterly and full-year results, including commentary on the company’s transformation journey and guidance for future periods. Capital markets announcements describe a comprehensive refinancing of the company’s debt capital structure, including exchange offers and consent solicitations involving senior secured notes, senior notes, convertible notes and term loans, as well as subsequent reports on high participation levels in these transactions.

Strategic and technology-focused news highlights Claritev’s efforts to modernize its infrastructure and expand its solutions. Examples include the decision to consolidate cloud infrastructure on Oracle Cloud Infrastructure to support digital transformation and the availability of the BenInsights analytics solution in the Oracle Cloud Marketplace for Oracle Cloud HCM customers. Other releases describe agreements with partners such as J2 Health to enhance network services and analytics, and references by ClearNote Health to Claritev’s PHCS and MultiPlan Networks in connection with access to cancer detection testing.

Together, these articles show how the company uses technology, data and AI to support payors, employers, patients, providers and third parties. For investors and observers researching MPLN, this news stream provides historical and transitional context leading into the Claritev era and the subsequent trading under the CTEV ticker. Users can review these updates to understand the company’s strategic priorities, transformation initiatives and partnerships over time.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.81%
Tags
partnership
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.73%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
conferences
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
29.07%
Tags
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-13.43%
Tags
-
Rhea-AI Summary

MultiPlan Corporation (NYSE: MPLN) announced it will release its first quarter 2023 financial results on May 4, 2023, at 8:00 am ET. A conference call will follow, and investors are encouraged to pre-register. The earnings press release and supplemental slide deck will be available on the Company's Investor Relations website. MultiPlan specializes in data analytics and technology-enabled cost management solutions for the U.S. healthcare sector, serving over 700 healthcare payors. This release highlights the upcoming financial reporting as a critical point for investors to monitor.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.78%
Tags
conferences earnings
Rhea-AI Summary

MultiPlan Corporation (NYSE:MPLN) has published its inaugural 2022 Environmental, Social, and Governance (ESG) Report, outlining its efforts to manage ESG risks and opportunities in the U.S. healthcare sector. The report reflects practices founded on frameworks like the Sustainable Accounting Standards Board (SASB) Standards and United Nations Sustainable Development Goals (UN SDGs). Key highlights include local financial support through Rural Health Grants, enhanced IT security, a Diversity and Inclusion Plan, and a centralized enterprise risk management program. The full report is available on the company's website.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.91%
Tags
none
-
Rhea-AI Summary

MultiPlan Corporation (NYSE: MPLN) reported its Q4 2022 results with revenues of $241.1 million and a net loss of $650.1 million, which includes a substantial impairment charge of $662.2 million. For the full year 2022, revenues totaled $1,079.7 million, with a net loss of $572.9 million. The company anticipates 2023 revenues between $925 million and $975 million and adjusted EBITDA between $600 million and $650 million. MultiPlan repurchased over $136 million of its 5.75% Notes and authorized a $100 million share repurchase program through December 31, 2023. The company processed $155.2 billion in medical charges, identifying $22.3 billion in potential savings.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1%
Tags
-
Rhea-AI Summary

MultiPlan Corporation (NYSE:MPLN) has announced a new share repurchase program authorizing up to $100 million in stock buybacks, valid through December 31, 2023. This decision reflects the company's belief that its shares are currently undervalued and is part of a broader strategy focused on driving long-term shareholder value. Although primarily aimed at growth and debt reduction, the buyback program underscores confidence in the company's operational strength and cash flow. Shares may be repurchased through various methods, with no guaranteed number of shares specified.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1%
Tags
buybacks
Rhea-AI Summary

MultiPlan Corporation (NYSE:MPLN), a leader in healthcare cost management and data analytics, announced management participation in key conferences this March 2023. The events include Citi's Healthcare Services Conference on March 2 in New York, J.P. Morgan's Global High Yield & Leverage Finance Conference on March 7-8 in Miami Beach, and Barclays' Global Healthcare Conference on March 14, also in Miami Beach. Investors can access a live webcast and audio archive of these events through the investor relations section of MultiPlan's website. MultiPlan supports over 700 healthcare payors with innovative solutions to improve competitiveness and manage care costs.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.82%
Tags
conferences

FAQ

What is the current stock price of Multiplan Corporation (MPLN)?

The current stock price of Multiplan Corporation (MPLN) is $23.15 as of April 29, 2025.

What is the market cap of Multiplan Corporation (MPLN)?

The market cap of Multiplan Corporation (MPLN) is approximately 295.3M.
Multiplan Corporation

NYSE:MPLN

MPLN Rankings

MPLN Stock Data

295.29M
8.53M
Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
Services-business Services, Nec
US
NEW YORK